Polymyositis and dermatomyositis epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Polymyositis and dermatomyositis}} {{CMG}}; {{AE}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *The incidence of polymyositis and dermatomyos..." |
|||
Line 12: | Line 12: | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of polymyositis and dermatomyositis is approximately 5-22 per 100,000 individuals worldwide.<ref name="pmid9281381">{{cite journal |vauthors=Jacobson DL, Gange SJ, Rose NR, Graham NM |title=Epidemiology and estimated population burden of selected autoimmune diseases in the United States |journal=Clin. Immunol. Immunopathol. |volume=84 |issue=3 |pages=223–43 |date=September 1997 |pmid=9281381 |doi= |url=}}</ref> | *The prevalence of polymyositis and dermatomyositis is approximately 5-22 per 100,000 individuals worldwide.<ref name="pmid9281381">{{cite journal |vauthors=Jacobson DL, Gange SJ, Rose NR, Graham NM |title=Epidemiology and estimated population burden of selected autoimmune diseases in the United States |journal=Clin. Immunol. Immunopathol. |volume=84 |issue=3 |pages=223–43 |date=September 1997 |pmid=9281381 |doi= |url=}}</ref> | ||
*In | *In 2003,the prevalence of polymyositis and dermatomyositis was estimated to be 21.5 cases per 100,000 individuals in Quebec.<ref name="BernatskyJoseph20082">{{cite journal|last1=Bernatsky|first1=S|last2=Joseph|first2=L|last3=Pineau|first3=C A|last4=Belisle|first4=P|last5=Boivin|first5=J F|last6=Banerjee|first6=D|last7=Clarke|first7=A E|title=Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences|journal=Annals of the Rheumatic Diseases|volume=68|issue=7|year=2008|pages=1192–1196|issn=0003-4967|doi=10.1136/ard.2008.093161}}</ref> | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
Line 29: | Line 29: | ||
*Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1. | *Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1. | ||
===Region=== | ===Region=== | ||
* | *Prevalence of polymyositis and dermatomyositis are lower in young rural men and higher in older urban women.<ref name="BernatskyJoseph2008">{{cite journal|last1=Bernatsky|first1=S|last2=Joseph|first2=L|last3=Pineau|first3=C A|last4=Belisle|first4=P|last5=Boivin|first5=J F|last6=Banerjee|first6=D|last7=Clarke|first7=A E|title=Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences|journal=Annals of the Rheumatic Diseases|volume=68|issue=7|year=2008|pages=1192–1196|issn=0003-4967|doi=10.1136/ard.2008.093161}}</ref> | ||
===Developed Countries=== | ===Developed Countries=== |
Revision as of 14:50, 9 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis epidemiology and demographics |
FDA on Polymyositis and dermatomyositis epidemiology and demographics |
CDC on Polymyositis and dermatomyositis epidemiology and demographics |
Polymyositis and dermatomyositis epidemiology and demographics in the news |
Blogs on Polymyositis and dermatomyositis epidemiology and demographics |
Risk calculators and risk factors for Polymyositis and dermatomyositis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence of polymyositis and dermatomyositis is approximately 2 per 100,000 individuals worldwide.[1]
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of polymyositis and dermatomyositis is approximately 5-22 per 100,000 individuals worldwide.[1]
- In 2003,the prevalence of polymyositis and dermatomyositis was estimated to be 21.5 cases per 100,000 individuals in Quebec.[2]
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop polymyositis and dermatomyositis.
- Polymyositis and dermatomyositis commonly affects patients in 40-50 years of age.
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Females are more commonly affected by polymyositis and dermatomyositis than males. The female to male ratio is approximately 2 to 1.
Region
- Prevalence of polymyositis and dermatomyositis are lower in young rural men and higher in older urban women.[3]
Developed Countries
Developing Countries
References
- ↑ 1.0 1.1 Jacobson DL, Gange SJ, Rose NR, Graham NM (September 1997). "Epidemiology and estimated population burden of selected autoimmune diseases in the United States". Clin. Immunol. Immunopathol. 84 (3): 223–43. PMID 9281381.
- ↑ Bernatsky, S; Joseph, L; Pineau, C A; Belisle, P; Boivin, J F; Banerjee, D; Clarke, A E (2008). "Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences". Annals of the Rheumatic Diseases. 68 (7): 1192–1196. doi:10.1136/ard.2008.093161. ISSN 0003-4967.
- ↑ Bernatsky, S; Joseph, L; Pineau, C A; Belisle, P; Boivin, J F; Banerjee, D; Clarke, A E (2008). "Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences". Annals of the Rheumatic Diseases. 68 (7): 1192–1196. doi:10.1136/ard.2008.093161. ISSN 0003-4967.